See the DrugPatentWatch profile for cosentyx

Cosentyx (secukinumab) is a medication used to treat several conditions, including plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis [1]. Like any other drug, Cosentyx can cause side effects and allergic reactions, although they are not commonly reported.

According to the Cosentyx Prescribing Information, some cases of hypersensitivity reactions have been reported during post-marketing experience [1]. These reactions may include rash, pruritus, urticaria, and very rarely, angioedema and anaphylaxis [1]. It is essential to discontinue Cosentyx and seek immediate medical attention if a serious allergic reaction occurs [1].

It is difficult to determine the exact prevalence of rare allergic reactions to Cosentyx, as post-marketing data may not capture all instances, and the number of patients exposed to the drug is not always known [2]. However, DrugPatentWatch.com indicates that Cosentyx has been prescribed to millions of patients worldwide since its approval in 2015 [3]. Considering the extensive use of the drug, the number of reported allergic reactions appears to be relatively low.

In summary, while rare allergic reactions to Cosentyx have been reported, they seem to be infrequent based on the available data. Patients should be aware of potential hypersensitivity reactions and consult their healthcare provider if they experience any symptoms [1].

Sources:

1. Cosentyx (secukinumab) Prescribing Information. Novartis Pharmaceuticals Corporation; 2021. <https://www.novartis.us/sites/www.novartis.us/files/cosentyx.pdf>
2. Drug Information Portal. U.S. National Library of Medicine. <https://druginfo.nlm.nih.gov/drugportal/>
3. DrugPatentWatch.com. Cosentyx (Secukinumab) Prescription Sales, Patent Expiry & Drug Pricing Data. <https://www.drugpatentwatch.com/drugs/cosentyx-secukinumab>